bezafibrate has been researched along with Chronic Illness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Düll, MM; Kremer, AE | 1 |
| Hirano, K; Isayama, H; Koike, K; Mizuno, S; Nakai, Y; Omata, M; Sasahira, N; Tada, M; Watanabe, T; Yamamoto, N | 1 |
| Harada, N; Hidaka, M; Inoue, Y; Iwasaki, S; Kawakita, T; Kawano, F; Kiyokawa, T; Matsui, T; Nagakura, S; Onishi, S; Saibara, T; Sakai, T; Takahashi, M; Takemoto, S | 1 |
| Benderly, M; Boyko, V; Goldbourt, U | 1 |
| Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
| Hata, T; Ishikawa, K; Kitagawa, Y; Ohta, T; Shinohara, Y; Tomiyasu, H; Yamamoto, M | 1 |
| Kimura, T; Kita, R; Kokuryu, H; Osaki, Y; Takamatsu, S; Tomono, N | 1 |
| Bresolin, N; Ferrò, MT; Fortunato, F; Gagliardi, E; Messina, C; Mileto, G; Pitrone, F; Toscano, A; Vita, G | 1 |
1 review(s) available for bezafibrate and Chronic Illness
| Article | Year |
|---|---|
Management of Chronic Hepatic Itch.
Topics: Analgesics, Opioid; Anion Exchange Resins; Antipruritics; Bezafibrate; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 Enzyme Inducers; Drainage; Humans; Hypolipidemic Agents; Membrane Glycoproteins; Methylamines; Narcotic Antagonists; Prevalence; Pruritus; Rifampin; Thiazepines; Ursodeoxycholic Acid | 2018 |
3 trial(s) available for bezafibrate and Chronic Illness
| Article | Year |
|---|---|
Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis.
Topics: Administration, Oral; Adult; Aged; Bezafibrate; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hospitals, University; Humans; Japan; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2015 |
Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia.
Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Male; Pravastatin; Solubility; Stroke; Triglycerides | 2005 |
Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels.
Topics: Aged; Alkaline Phosphatase; Bezafibrate; Biliary Tract; Chronic Disease; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Treatment Outcome | 2006 |
4 other study(ies) available for bezafibrate and Chronic Illness
| Article | Year |
|---|---|
Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Bezafibrate; Chronic Disease; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous | 2010 |
Relation of body mass index to mortality among men with coronary heart disease.
Topics: Aged; Bezafibrate; Body Mass Index; Chronic Disease; Comorbidity; Coronary Disease; Data Interpretation, Statistical; Humans; Hypolipidemic Agents; Israel; Male; Middle Aged; Randomized Controlled Trials as Topic; Registries; Risk Factors | 2010 |
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism.
Topics: Bezafibrate; Biopsy; Carbohydrate Metabolism; Chronic Disease; Humans; Lipid Metabolism; Male; Middle Aged; Mitochondria, Muscle; Muscles; Muscular Diseases; Uremia | 1993 |